HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine: What about safety in France?

被引：0
作者：
Ativon, F. [1 ]
Lebeller, C. [2 ]
Schiestel, T. [3 ]
Grandvuillemin, A. [4 ]
Davani, S. [1 ]
Valnet-Rabier, M. B. [1 ]
机构：
[1] Ctr Reg Pharmacovigilance Franche Comte, Besancon, France
[2] Ctr Reg Pharmacovigilance Paris, HEGP, Paris, France
[3] Ctr Reg Pharmacovigilance Paris Fernand Widal, Paris, France
[4] Ctr Reg Pharmacovigilance Bourgogne, Dijon, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2021年 / 35卷
关键词：
HIV PrEP; TDF/emtricitabine; safety;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-117
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [41] Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure
    Inciarte, A.
    Leal, L.
    Gonzalez, E.
    Leon, A.
    Lucero, C.
    Mallolas, J.
    Torres, B.
    Laguno, M.
    Rojas, J.
    Martinez-Rebollar, M.
    Gonzalez-Cordon, A.
    Cruceta, A.
    Arnaiz, J. A.
    Gatell, J. M.
    Garcia, F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (10) : 2857 - 2861
  • [42] Association of tenofovir disoproxil fumarate with primary allograft survival in HIV-positive kidney transplant recipients
    Boyle, Suzanne M.
    Malat, Gregory
    Harhay, Meera N.
    Lee, Dong H.
    Pang, Lisa
    Talluri, Sindhura
    Sharma, Akshay
    Bias, Tiffany E.
    Ranganna, Karthik
    Doyle, Alden M.
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (04)
  • [43] Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy
    Nishijima, Takeshi
    Kurosawa, Takuma
    Tanaka, Noriko
    Kawasaki, Yohei
    Kikuchi, Yoshimi
    Oka, Shinichi
    Gatanaga, Hiroyuki
    AIDS, 2016, 30 (10) : 1563 - 1571
  • [44] A Randomized Study of Tenofovir Disoproxil Fumarate in Treatment-experienced HIV-1 Infected Adolescents
    Della Negra, Marinella
    de Carvalho, Aroldo Prohmann
    de Aquino, Maria Zilda
    Nolasco da Silva, Marcos Tadeu
    Pinto, Jorge
    White, Kirsten
    Arterburn, Sarah
    Liu, Ya-Pei
    Enejosa, Jeffrey V.
    Cheng, Andrew K.
    Chuck, Steven L.
    Rhee, Martin S.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (05) : 469 - 473
  • [45] Safety of Tenofovir Disoproxil Fumarate Among Breastfeeding Infants of Patients With Chronic Hepatitis B: A Systematic Review
    Pak, Kevin
    Ibrahim, Brittney
    Saab, Sammy
    JOURNAL OF VIRAL HEPATITIS, 2024, 31 (11) : 760 - 767
  • [46] Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients
    Huang, Yu-Shan
    Cheng, Chien-Yu
    Sun, Hsin-Yun
    Cheng, Shu-Hsing
    Lu, Po-Liang
    Lee, Chen-Hsiang
    Lee, Yuan-Ti
    Tsai, Hung-Chin
    Yang, Chia-Jui
    Liu, Chun-Eng
    Liou, Bo-Huang
    Lin, Shih-Ping
    Huang, Sung-Hsi
    Ho, Mao-Wang
    Tang, Hung-Jen
    Hung, Chien-Ching
    MICROBIOLOGY SPECTRUM, 2023, 11 (03):
  • [47] Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naive Patients with Chronic Hepatitis B in Korea
    Kwon, Jung Hyun
    Song, Myeong Jun
    Jang, Jeong Won
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Kim, Hee Yeon
    Kim, Chang Wook
    Song, Do Seon
    Chang, U. Im
    Yang, Jin Mo
    You, Chan Ran
    Choi, Sang Wook
    Lee, Hae Lim
    Lee, Sung Won
    Han, Nam Ik
    Nam, Soon Woo
    Kim, Sang Gyune
    Kim, Young Seok
    Kim, Seok Hyun
    Lee, Byung Seok
    Lee, Tae Hee
    Cho, Eun-Young
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (07) : 2039 - 2048
  • [48] Long-term renal and bone safety of tenofovir disoproxil fumarate in chronic hepatitis B patients
    Butt, N.
    Rai, L.
    Hussain, R.
    Khemani, H.
    Ali, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 84 - 84
  • [49] Efficacy, Safety and Pharmacokinetics of Tenofovir Disoproxil Fumarate in Virologic-Suppressed HIV-infected Children Using Weight-Band Dosing
    Aurpibul, Linda
    Cressey, Tim R.
    Sricharoenchai, Sirintip
    Wittawatmongkol, Orasri
    Sirisanthana, Virat
    Phongsamart, Wanatpreeya
    Sudjaritruk, Tavitiya
    Chokephaibulkit, Kulkanya
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (04) : 392 - 397
  • [50] Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study
    DeJesus, Edwin
    Ramgopal, Moti
    Crofoot, Gordon
    Ruane, Peter
    LaMarca, Anthony
    Mills, Anthony
    Martorell, Claudia T.
    de Wet, Joseph
    Stellbrink, Hans-Jurgen
    Molina, Jean-Michel
    Post, Frank A.
    Valero, Ignacio Perez
    Porter, Danielle
    Liu, Yapei
    Cheng, Andrew
    Quirk, Erin
    SenGupta, Devi
    Cao, Huyen
    LANCET HIV, 2017, 4 (05): : E205 - E213
12345